MDR1 and ERCC1 Expression Predict Outcome of Patients with Locally Advanced Bladder Cancer Receiving Adjuvant Chemotherapy

MLA

Andreas-Claudius Hoffmann, et al. “MDR1 and ERCC1 Expression Predict Outcome of Patients with Locally Advanced Bladder Cancer Receiving Adjuvant Chemotherapy.” Neoplasia: An International Journal for Oncology Research, vol. 12, no. 8, Aug. 2010, pp. 628–36. EBSCOhost, https://doi.org/10.1593/neo.10402.

APA

Andreas-Claudius Hoffmann, Peter Wild, Christina Leicht, Simone Bertz, Kathleen D. Danenberg, Peter V. Danenberg, Robert Stöhr, Michael Stöckle, Jan Lehmann, Martin Schuler, & Arndt Hartmann. (2010). MDR1 and ERCC1 Expression Predict Outcome of Patients with Locally Advanced Bladder Cancer Receiving Adjuvant Chemotherapy. Neoplasia: An International Journal for Oncology Research, 12(8), 628–636. https://doi.org/10.1593/neo.10402

Chicago

Andreas-Claudius Hoffmann, Peter Wild, Christina Leicht, Simone Bertz, Kathleen D. Danenberg, Peter V. Danenberg, Robert Stöhr, et al. 2010. “MDR1 and ERCC1 Expression Predict Outcome of Patients with Locally Advanced Bladder Cancer Receiving Adjuvant Chemotherapy.” Neoplasia: An International Journal for Oncology Research 12 (8): 628–36. doi:10.1593/neo.10402.